- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03859583
Capsaicin Energy Expenditure and Glucose Metabolism (CAPS)
Capsaicin Consumption on Resting Energy Expenditure and Glucose Metabolism
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be recruited by posters distributed on campus bulletin boards and asked to contact the investigator by phone or e-mail. Participants will complete a screening questionnaire by phone to determine eligibility. Once they pass the screening, they will be invited to the laboratory to sign the consent form, which will be administered by Rafia Virk. They will also be given a demographic survey. The survey will inquire about height, weight, medical conditions, medications and inclusion/exclusion criteria and availability. This survey will be used for screening purposes only and will not contribute to the research data. The survey is included in this application and inclusion and exclusion criteria are outlined. If participants are determined eligible, they will be contacted to set up with two study visits, pre-test instructions will be provided.
*For both appointments, participants will arrive to the test location after a 12-hour fast.
Appointment 1: Participants will arrive at the Nutrition Assessment Laboratory between 7:00am and 7:30am. Details of the study will be re-iterated and informed consent will be obtained first thing on the morning of the first appointment. Eligibility will then then be confirmed by measuring height and weight and BMI calculation, and a over the counter pregnancy test will be performed on women. Demographic survey and 24-hour dietary recall will be obtained for 2 week days and 1 weekend day. Baseline measurements will then be obtained which include: Waist circumference, body compositition by Dual Energy X-ray Absorptiometry (DXA) scan (performed by Dr. de Jonge or Rafia Virk, who will be trained by Dr. de Jonge). The DXA scan involves lying on a table while wearing lose fitting, comfortable clothing. The scanner uses a low dose x-ray to determine the amount of fat, muscle and bone in your body. After lying down for 30 minutes, a metabolic cart will be used to measure resting energy expenditure by indirect calorimetry. For this procedure, a plastic dome will placed over the participants head that will measure their resting energy expenditure (REE). Baseline REE will then be measured for 30 minutes. After getting a baseline measure participants will consume a standard meal. We will continue to measure resting energy expenditure for 120 minutes. Blood glucose using a glucometer will also be determine before and 2 hours after the standardized meal. The REE measurements will be performed by Ms. Rafia Virk. Ms. Virk will be trained in the use of the metabolic cart by Dr. Lilian de Jonge who has over 20 years experience in the use of indirect calorimetry for the assessment of REE. After this test, the subjects will undergo a capsaicin threshold test. For this test, deionized water with red food coloring will serve as the blank. The testing compound will be cayenne pepper. The target samples, containing very low concentrations of cayenne pepper (0-1mg/g), will also have red food coloring so that they will only be distinguishable to participant by sense of taste rather than taste and sight. There will be nine sets of rows, each with 3 sets of samples. Each set will contain 2 blanks and one target sample. The target sample increase in concentration as the participant moves along the row. The participant will be asked to taste test the samples and pick the target sample out of the three. This appointment will take about 3 hours.
The second test day will occur within one week of the first day. The participant will arrive with a 12 hour fast during the first week of the study. They will consume the same standardized meal (provided by Dr. de Jonge) from first appointment but with the addition of capsaicin (cayenne pepper powder form) (4tsp). They will then undergo a metabolic cart test (120 mins). Their blood glucose will also be determined using a glucometer for the following 3 hours post consumption. This appointment will last about 3 hours.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elisabeth de Jonge, PhD
- Phone Number: 7039935153
- Email: edejonge@gmu.edu
Study Contact Backup
- Name: Rafia VIrk, BSc
- Phone Number: 7039935153
- Email: rvirk@gmu.edu
Study Locations
-
-
Virginia
-
Fairfax, Virginia, United States, 22030
- Recruiting
- George Mason University
-
Contact:
- Elisabeth de Jonge
- Phone Number: 703-993-5153
- Email: edejonge@gmu.edu
-
Contact:
- Rafia Virk
- Phone Number: 7039935153
- Email: rvirk@gmu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
18-45 years of age females or 18-50 males
- Generally healthy non-diabetic overweight or obese men and women
- BMI 23-33 kg/m2
- Willing to abstain from caffeine and alcohol for 3 days prior to testing
- Able to provide written consent in English
- Ability to communicate in English (oral and written)
Exclusion Criteria:
BMI < 23 kg/m2 or >33 kg/m2
- Pregnant or Nursing
- Taking prescribed or over the counter medication affecting fluid balance or metabolism
- Suffers from hepatic, renal, pulmonary, endocrine or hematological disease
- Performs more than 3 hours a week of strenuous exercise
- Consumes, on average, more than 2 alcoholic beverages per day
- More than 5 kg of weight change over the past 6 months
- Claustrophobic
- Consumes capsaicin foods habitually 3x/week
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Capsaicin
4 tsp of cayenne pepper in a 60g omelette
|
4 tsp of cayenne in a breakfast omelette
|
Placebo Comparator: Control
60 g omelette
|
breakfast omelette without cayenne pepper
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial substrate oxidation
Time Frame: 3 hours
|
The change in substrate oxidation after a meal as measured by the ratio of carbondioxide production and oxygen consumption measured by indirect calorimetry
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postprandial energy expenditure
Time Frame: 3 hrs
|
Change in resting energy expenditure after meal consumption as measured by indirect calorimetry
|
3 hrs
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1157054-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on Capsaicin
-
University of FloridaCompletedPain | FibromyalgiaUnited States
-
Nantes University HospitalRecruitingNeuropathic Pain | Coccyx Disorder | CoccygodyniaFrance
-
University of FloridaCompleted
-
NeurogesXCompletedHIV Infections | Pain | Peripheral Nervous System Diseases
-
Hospital de MataróInstituto de Salud Carlos III; Consorci Sanitari del MaresmeRecruitingStroke | Oropharyngeal Dysphagia | Swallowing Disorder | Stroke, ComplicationSpain
-
Samyang Biopharmaceuticals CorporationCompletedPostherpetic Neuralgia | Peripheral Nerve InjuryKorea, Republic of
-
Propella TherapeuticsCompletedPain | Osteoarthritis, KneeUnited States
-
The University of Texas Health Science Center,...University of California, San FranciscoActive, not recruitingMigraine | Cluster Headache | Trigeminal Autonomic Cephalgia | Hemicrania Continua | Paroxysmal Hemicrania | SUNCT | Short-Lasting Unilateral Neuralgiform Headache With Conjunctival Injection and TearingUnited States
-
Averitas Pharma, Inc.RecruitingPost Surgical Neuropathic PainUnited States, Spain, France, Netherlands, Poland, United Kingdom
-
Carilion ClinicChorda Pharma, Inc.Completed